Influenza Drug Therapy

The influenza virus is a common viral infection that can rapidly evolve and render previous vaccines ineffective. There are two types of FDA approved drug treatments for the influenza virus, neuraminidase inhibitors and M2-inhibitors. Discover the latest research on influenza drug therapy here.

August 5, 2020

Identification of a novel TLR5 agonist derived from the P97 protein of Mycoplasma hyopneumoniae

Immunobiology
Laurie GauthierDenis Archambault
July 24, 2020
Open Access

Sequence analysis and pathogenicity of Avian Orthoavulavirus 1 strains isolated from poultry flocks during 2015-2019

BMC Veterinary Research
Hatem S Abd El-HamidAhmed R Elbestawy
August 4, 2020
Open Access

No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children

Journal of Translational Autoimmunity
Krister MelénIlkka Julkunen
August 13, 2020
Open Access

Responses to the Sb epitope contributed to antigenic drift of the influenza A 2009 H1N1 virus

Archives of Virology
S KetklaoOrnpreya Suptawiwat
August 5, 2020

Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface

The Journal of Clinical Investigation
Jinhui DongJames E Crowe
August 3, 2020

Design and synthesis of pinane oxime derivatives as novel anti-influenza agents

Bioorganic Chemistry
Jianghong DongWenhui Hu
July 9, 2020
Open Access

A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies

BioRxiv : the Preprint Server for Biology
Priyamvada AcharyaBarton F Haynes
August 12, 2020
Open Access

Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza

PLoS Pathogens
Claire ScottStephen Griffin
July 16, 2020
Review

Imprinting, immunodominance, and other impediments to generating broad influenza immunity

Immunological Reviews
Matthew KnightPatrick C Wilson
August 13, 2020
Open Access

Plasticity of the 340-Loop in Influenza Neuraminidase Offers New Insight for Antiviral Drug Development

International Journal of Molecular Sciences
Nanyu HanZunxi Huang
July 31, 2020
Preprint
Open Access

Limited predictability of amino acid substitutions in seasonal influenza viruses

BioRxiv : the Preprint Server for Biology
P. Barrat-CharlaixRichard Neher

Sign up to follow this feed and discover related papers.

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2020 Meta ULC. All rights reserved
/feed-previews/influenza-drug-therapy/c666b72e-0a4d-4638-a97a-37979d796eef